Product Description: Eldacimibe is an ACAT2 inhibitor. Eldacimibe can lower plasma cholesterol levels by blocking cholesterol absorption and can prevent macrophages from turning into foam cells. Eldacimibe can be used in the study of cardiovascular diseases (atherosclerosis), endocrine and metabolic diseases (hypercholesterolemia) [1].
Formula: C39H58N2O5
References: [1]Chhabria M T, et al. Update on patented cholesterol absorption inhibitors[J]. Expert Opinion on Therapeutic Patents, 2009, 19(8): 1083-1107.
CAS Number: 141993-70-6
Molecular Weight: 634.89
Research Area: Metabolic Disease; Cardiovascular Disease
Solubility: 10 mM in DMSO
Target: Acyltransferase